Gene und Risikofaktoren bei der juvenilen idiopathischen Arthritis

Zusammenfassung

Die juvenile idiopathische Arthritis (JIA) ist keine Erberkrankung im klassischen Sinne, und doch haben erbliche Faktoren einen entscheidenden Einfluss auf Krankheitsempfänglichkeit und Verlauf. In den vergangenen Jahren konnten wichtige genetische Befunde bei der JIA erhoben werden:
1.Die Konkordanz bei Geschwistern ist bezüglich der Inzidenz relativ niedrig, jedoch bezüglich Subtyp und Verlauf hoch.
2.Die Subtypen der JIA haben unterschiedliche genetische Hintergründe.
3.Es gibt JIA-Patienten, die keines der bislang definierten Risikogene tragen.
4.Einige Formen der JIA haben einen klar von der rheumatoiden Arthritis des Erwachsenen abgrenzbaren genetischen Hintergrund.
5.Mehrere Faktoren beeinflussen die Pathogenese, wobei genetische und umweltbedingte Faktoren eine Rolle spielen.
6.Genetische Faktoren beeinflussen auch den Verlauf der Erkrankung, z. B. das Auftreten bestimmter Komplikationen.
7.Genetische Faktoren, die ein erhöhtes Therapierisiko vermitteln, müssen bei therapeutischen Entscheidungen berücksichtigt werden.
Das wachsende Wissen um genetische und expositionelle Faktoren bei der JIA ist für unser pathogenetisches Verständnis, die Klassifikation und die Therapieplanung von Bedeutung. Verbesserte Kenntnisse sind jedoch auch bei der Beantwortung von Fragen der Patienten und Angehörigen hilfreich. Diese adressieren den Wunsch nach besserem Krankheitsverständnis, einer Risikoabwägung für Geschwister und Kinder der Betroffenen und häufig auch Schuldgefühle. Eine behutsame und korrekte Information ist daher besonders erforderlich.

Abstract

Juvenile idiopathic arthritis (JIA) is not an inherited disease transmitted with a classical genetic pathway but genetic factors have reasonable influence on disease susceptibility. Within recent years, several factors have been defined affecting susceptibility and course of the disease. This review summarizes our current knowledge:
1.Affected siblings have a low concordant incidence of the disease, but a high concordance of its subtype and course.
2.Subtypes of JIA have different genetic backgrounds.
3.Some JIA patients do not carry any of the defined risk genes at all.
4.Most of the subtypes of JIA have a genetic background distinct from rheumatoid arthritis in adults.
5.There are multiple factors involved in the pathogenesis implying genetic and environmental factors.
6.Genetic factors are not only involved in disease susceptibility but also in the course of the disease and the occurrence of complications.
7.Genetic factors responsible for an increased risk of complications will have an increasing influence on therapeutic decisions.
Patients and their relatives frequently ask questions addressing the pathogenesis and the risk of disease transmission within the family. Moreover, parents frequently present with a guilty feeling. Physicians have to deal with all these issues thoroughly and with great empathy for the family’s situation. The knowledge of the factors involved in the pathogenesis of JIA has considerably progressed in the past decade but continues to remain a challenge.

Juvenile idiopathische Arthritis - Genetik - Vererbung - Risikofaktoren

Juvenile idiopathic arthritis - genetics - heridity - risk factors

Literatur

• 1 Petty R E, Southwood T R, Baum J. et al . Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.  J Rheumatol. 1998;  25 1991
• 2 Desaymard C, Kaplan C, Fournier C. et al . Major histocompatibility complex markers and disease heterogeneity in one hundred eight patients with systemic onset juvenile chronic arthritis.  Rev Rhum Engl. 1996;  63 9
• 3 Oen K, Malleson P N, Cabral D A. et al . Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations.  J Rheumatol. 2003;  30 585
• 4 De Benedetti F, Meazza C, Vivarelli M. et al . Functional and prognostic relevance of the - 173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.  Arthritis Rheum. 2003;  48 1398
• 5 Ogilvie E M, Fife M S, Thompson S D. et al . The - 174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families.  Arthritis Rheum. 2003;  48 3202
• 6 Ansell B M. Juvenile chronic arthritis and juvenile spondyloarthropathy.  Curr Opin Rheumatol. 1991;  3 838
• 7 Brunner H I, Ivaskova E, Haas J P. et al . Class I associations and frequencies of class II HLA-DRB alleles by RFLP analysis in children with rheumatoid-factor-negative juvenile chronic arthritis.  Rheumatol Int. 1993;  13 83
• 8 Hall P J, Burman S J, Barash J. et al . HLA and complement C4 antigens in polyarticular onset seronegative juvenile chronic arthritis: association of early onset with HLA-DRw8.  J Rheumatol. 1989;  16 55
• 9 Runstadler J A, Saila H, Savolainen A. et al . Analysis of MHC region genetics in Finnish patients with juvenile idiopathic arthritis: evidence for different locus-specific effects in polyarticular vs pauciarticular subsets and a shared DRB1 epitope.  Genes Immun. 2003;  4 326
• 10 Flato B, Smerdel A, Johnston V. et al . The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis.  Arthritis Rheum. 2002;  46 986
• 11 Haas J P, Andreas A, Rutkowski B. et al . A model for the role of HLA-DQ molecules in the pathogenesis of juvenile chronic arthritis.  Rheumatol Int. 1991;  11 191
• 12 Ihle J, Fleckenstein B, Terreaux C. et al . Differential peptide binding motif for three juvenile arthritis associated HLA-DQ molecules.  Clin Exp Rheumatol. 2003;  21 257
• 13 Haas J P, Kimura A, Truckenbrodt H. et al . Early-onset pauciarticular juvenile chronic arthritis is associated with a mutation in the Y-box of the HLA-DQA1 promoter.  Tissue Antigens. 1995;  45 317
• 14 Fernandez S, Wassmuth R, Knerr I. et al . Relative quantification of HLA-DRA1 and -DQA1 expression by real-time reverse transcriptase-polymerase chain reaction (RT-PCR).  Eur J Immunogenet. 2003;  30 141
• 15 Adams B S, Cha H C, Cleary J. et al . DEK binding to class II MHC Y-box sequences is gene- and allele-specific.  Arthritis Res Ther. 2003;  5 R226
• 16 Fink C W, Stastny P. Pauciarticular juvenile rheumatoid arthritis: clinical and immunogenetic aspects.  Ann Rheum Dis. 1979;  38 (Suppl 1) 79
• 17 Schaller J G, Omenn G S. The histocompatibility system and human disease.  J Pediatr. 1976;  88 913
• 18 Zeggini E, Thomson W, Kwiatkowski D. et al . Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis.  Arthritis Rheum. 2002;  46 3304
• 19 Haas J P, Nevinny-Stickel C, Schoenwald U. et al . Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis.  Hum Immunol. 1994;  41 225
• 20 Balogh Z, Gyodi E, Petranyi G. et al . HLA-DR antigens in juvenile chronic arthritis.  J Rheumatol. 1982;  9 448
• 21 Forre O, Dobloug J H, Hoyeraal H M. et al . HLA antigens in juvenile arthritis. Genetic basis for the different subtypes.  Arthritis Rheum. 1983;  26 35
• 22 Melin-Aldana H, Giannini E H, Taylor J. et al . Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis.  J Pediatr. 1992;  121 56
• 23 Flato B, Lien G, Smerdel A. et al . Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.  J Rheumatol. 2003;  30 386
• 24 Hoffman R W, Shaw S, Francis L C. et al . HLA-DP antigens in patients with pauciarticular juvenile rheumatoid arthritis.  Arthritis Rheum. 1986;  29 1057
• 25 Murray K J, Szer W, Grom A A. et al . Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene.  J Rheumatol. 1997;  24 560
• 26 Zeggini E, Thomson W, Alansari A. et al . Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis.  Rheumatology (Oxford). 2002;  41 462
• 27 Paul C, Schoenwald U, Truckenbrodt H. et al . HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis.  Immunogenetics. 1993;  37 442
• 28 Rosenberg A M, Petty R E. Similar patterns of juvenile rheumatoid arthritis within families.  Arthritis Rheum. 1980;  23 951
• 29 Schaller J G, Ochs H D, Thomas E D. et al . Histocompatibility antigens in childhood-onset arthritis.  J Pediatr. 1976;  88 926
• 30 Burgos-Vargas R. Spondyloarthropathies and psoriatic arthritis in children.  Curr Opin Rheumatol. 1993;  5 634
• 31 Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J. Juvenile-onset spondyloarthropathies.  Rheum Dis Clin North Am. 1997;  23 569
• 32 Pryhuber K G, Murray K J, Donnelly P. et al . Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis.  J Rheumatol. 1996;  23 747
• 33 McGarry F, Walker R, Sturrock R. et al . The - 308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27.  J Rheumatol. 1999;  26 1110
• 34 Morris A, Rogers M, Fischer G. et al . Childhood psoriasis: a clinical review of 1262 cases.  Pediatr Dermatol. 2001;  18 188
• 35 Marcusson J A, Strom H, Lindvall N. Psoriasis, peripheral arthritis, sacroiliitis and juvenile chronic arthritis: a family study in relation to segregation of HLA antigens.  J Rheumatol. 1983;  10 619
• 36 Gonzalez S, Brautbar C, Martinez-Borra J. et al . Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population.  Hum Immunol. 2001;  62 632
• 37 Schmitt-Egenolf M, Eiermann T H, Boehncke W H. et al . Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study.  J Invest Dermatol. 1996;  106 711
• 38 Balding J, Kane D, Livingstone W. et al . Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity.  Arthritis Rheum. 2003;  48 1408
• 39 Gonzalez S, Martinez-Borra J, Lopez-Vazquez A. et al . MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis.  J Rheumatol. 2002;  29 973
• 40 von Koskull S, Truckenbrodt H, Holle R. et al . Incidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective study.  Ann Rheum Dis. 2001;  60 940
• 41 Moroldo M B, Tague B L, Shear E S. et al . Juvenile rheumatoid arthritis in affected sibpairs.  Arthritis Rheum. 1997;  40 1962
• 42 Saila H, Savolainen A, Kauppi M. et al . Occurrence of chronic inflammatory rheumatic diseases among parents of multiple offspring affected by juvenile idiopathic arthritis.  Clin Exp Rheumatol. 2003;  21 263
• 43 Clemens L E, Albert E, Ansell B M. Sibling pairs affected by chronic arthritis of childhood: evidence for a genetic predisposition.  J Rheumatol. 1985;  12 108
• 44 Prahalad S, Ryan M H, Shear E S. et al . Twins concordant for juvenile rheumatoid arthritis.  Arthritis Rheum. 2000;  43 2611
• 45 Fritsche E, Baek S J, King L M. et al . Functional characterization of cyclooxygenase-2 polymorphisms.  J Pharmacol Exp Ther. 2001;  299 468
• 46 Urano W, Taniguchi A, Yamanaka H. et al . Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses.  Pharmacogenetics. 2002;  12 183
• 47 Leipold G, Schutz E, Haas J P. et al . Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis.  Arthritis Rheum. 1997;  40 1896
• 48 Linden G J, Haworth S E, Maxwell A P. et al . The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.  J Periodontol. 2001;  72 808